23 October 2021 - The Australian Government is investing $40.5 million for a new Medicare Benefits Schedule item to improve the diagnosis and treatment of hypertension.
From 1 November, Australians will be able to claim rebates for ambulatory blood pressure measurement, which monitors a patient’s blood pressure continuously over 24 hours through a wearable device to diagnose if they are hypertensive or not.